| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/JVP.12182 |
| P8608 | Fatcat ID | release_u5a64c6e5rfojetywjnxq4aidy |
| P698 | PubMed publication ID | 25407884 |
| P50 | author | Sebastien H Bauquier | Q83147823 |
| Simon R. Bailey | Q39717298 | ||
| Elizabeth M. Tudor | Q47800066 | ||
| P2093 | author name string | E Tudor | |
| J R Bauquier | |||
| P2860 | cites work | The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cells | Q27022093 |
| Novel HMGB1-inhibiting therapeutic agents for experimental sepsis | Q33814903 | ||
| Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation | Q34156078 | ||
| The effect of oral metformin on insulin sensitivity in insulin-resistant ponies | Q34166697 | ||
| Synergistic activation of NF-{kappa}B by bacterial chemoattractant and TNF{alpha} is mediated by p38 MAPK-dependent RelA acetylation | Q34251052 | ||
| Metformin inhibits HMGB1 release in LPS‐treated RAW 264.7 cells and increases survival rate of endotoxaemic mice | Q34672050 | ||
| Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NF-κB pathway after traumatic brain injury in the rat. | Q35104577 | ||
| Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia. | Q39613461 | ||
| Anti-inflammatory activity of azithromycin as measured by its NF-kappaB, inhibitory activity | Q39744364 | ||
| Azithromycin reduces tumor necrosis factor-alpha production in lipopolysaccharide-stimulated THP-1 monocytic cells by modification of stress response and p38 MAPK pathway | Q39822510 | ||
| Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells | Q40185293 | ||
| Ethyl pyruvate diminishes the inflammatory response to lipopolysaccharide infusion in horses | Q40275623 | ||
| Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells | Q40331177 | ||
| Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation | Q40380708 | ||
| Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock | Q41662628 | ||
| Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells | Q42025731 | ||
| Ethyl pyruvate decreases proinflammatory gene expression in lipopolysaccharide-stimulated equine monocytes | Q42745547 | ||
| Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro | Q43108065 | ||
| Differential inhibition of equine neutrophil function by phosphodiesterase inhibitors. | Q43736166 | ||
| Immunopharmacological potential of selective phosphodiesterase inhibition. I. Differential regulation of lipopolysaccharide-mediated proinflammatory cytokine (interleukin-6 and tumor necrosis factor-alpha) biosynthesis in alveolar epithelial cells | Q43863064 | ||
| Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. | Q43986552 | ||
| Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock | Q44236446 | ||
| In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine blood | Q44384324 | ||
| Effects of oral clenbuterol on the clinical and inflammatory response to endotoxaemia in the horse | Q45791487 | ||
| ASP3258, an orally active potent phosphodiesterase 4 inhibitor with low emetic activity | Q48287601 | ||
| Effects of continuous or intermittent lipopolysaccharide administration for 48 hours on the systemic inflammatory response in horses | Q48621789 | ||
| P433 | issue | 3 | |
| P921 | main subject | whole blood | Q7997549 |
| P304 | page(s) | 290-296 | |
| P577 | publication date | 2014-11-19 | |
| P1433 | published in | Journal of Veterinary Pharmacology and Therapeutics | Q15753250 |
| P1476 | title | Anti-inflammatory effects of four potential anti-endotoxaemic drugs assessed in vitro using equine whole blood assays | |
| P478 | volume | 38 |
| Q92381511 | A Review on The Protective Effects of Metformin in Sepsis-Induced Organ Failure |
| Q92254014 | Anti-inflammatory effects of a p38 MAP kinase inhibitor, doramapimod, against bacterial cell wall toxins in equine whole blood |
| Q38626464 | Effects of polymyxin-B on TNF-α production in equine whole blood stimulated with three different bacterial toxins |
| Q40506281 | Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana). |
| Q92856263 | Modulation of TNF-α, IL-1Ra and IFN-γ in equine whole blood culture by glucocorticoids |
Search more.